Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study.

Source:http://linkedlifedata.com/resource/pubmed/id/12477620

Download in:

View as

General Info

PMID
12477620